Doctors Transplanted a Pig Kidney Into a Person a Month Ago. It’s Still Working.

[ad_1] A genetically modified pig kidney transplanted into a brain-dead person has worked for 32 days and counting, advancing efforts to use animals to ease perennial shortages for humans. [ad_2]…

Neuroscientists recreate Pink Floyd song from recorded brain waves

[ad_1] Neuroscientists were able to recreate ‘Another Brick in the Wall, Part 1’ using AI to decipher the brain’s electrical activity. The reconstructed Pink Floyd song represents a breakthrough that…

Ozempic Settles the Obesity Debate: It’s Biology Over Willpower

[ad_1] Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. [ad_2] Source link

Scientists close to developing a drug that makes teeth regrow

[ad_1] While we are used to the idea of teeth only growing twice, a new drug could make it possible to grow a third set. Scientists are making significant strides…

Global Red Biotechnology Research Report 2023 – ResearchAndMarkets.com

[ad_1] Global Red Biotechnology Research Report 2023 …  WV News [ad_2] Source link

New molecules could ‘fuel revolution in cancer treatment’

[ad_1] The molecules take a unique approach to combat cancer by rewiring mutated cancer-driving genes to self-destruct. Researchers have created a new molecule that they say could revolutionise cancer therapy.…

Family of Henrietta Lacks, Whose Unique Cells Changed Science, Settles With Thermo Fisher

[ad_1] What to Read Next [ad_2] Source link

Biogen’s New Boss Is Delivering, but Stock Isn’t Pricing It in Yet

[ad_1] The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity. [ad_2] Source link

Structural and dynamical investigation of histone H2B in well-hydrated nucleosome core particles by solid-state NMR – Communications Biology

[ad_1] Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251–260…

As Washington Clamps Down on Big Pharma, Small Is Beautiful Again

[ad_1] Large drug companies need innovation to deal with the drug-pricing law. That is a boon to smaller biotech firms. [ad_2] Source link